Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory (Oncotarget (2017) 8 (41806-41814) DOI: 10.18632/oncotarget.16018

Natalia Paez Arango, Lauren Brusco, Kenna R.Mills Shaw, Ken Chen, Agda Karina Eterovic, Vijaykumar Holla, Amber Johnson, Beate Litzenburger, Yekaterina B. Khotskaya, Nora Sanchez, Ann Bailey, Xiaofeng Zheng, Chacha Horombe, Scott Kopetz, Carol J. Farhangfar, Mark Routbort, Russell Broaddus, Elmer V. Bernstam, John Mendelsohn, Gordon B. MillsFunda Meric-Bernstam

    Research output: Contribution to journalComment/debate

    Abstract

    This article has been corrected: The Acknowledgements information has been updated. The proper Acknowledgements section is shown below:.

    Original languageEnglish (US)
    Number of pages1
    JournalOncotarget
    Volume10
    Issue number50
    DOIs
    StatePublished - Jan 1 2019

      Fingerprint

    ASJC Scopus subject areas

    • Oncology

    Cite this

    Arango, N. P., Brusco, L., Shaw, K. R. M., Chen, K., Eterovic, A. K., Holla, V., Johnson, A., Litzenburger, B., Khotskaya, Y. B., Sanchez, N., Bailey, A., Zheng, X., Horombe, C., Kopetz, S., Farhangfar, C. J., Routbort, M., Broaddus, R., Bernstam, E. V., Mendelsohn, J., ... Meric-Bernstam, F. (2019). Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory (Oncotarget (2017) 8 (41806-41814) DOI: 10.18632/oncotarget.16018. Oncotarget, 10(50). https://doi.org/10.18632/oncotarget.27176